INIS
patients
100%
humans
66%
proteins
46%
drugs
44%
comparative evaluations
44%
levels
40%
reviews
39%
diseases
36%
data
35%
evaluation
35%
receptors
34%
anticoagulants
33%
risks
32%
cancer
32%
plasma
31%
genes
30%
inflammation
28%
in vitro
26%
rats
26%
concentration
25%
performance
24%
thrombin
24%
assessments
23%
laboratories
23%
inhibition
22%
mice
21%
antibodies
21%
synthesis
21%
control
21%
doses
19%
sleep
19%
values
18%
covid-19
18%
sensitivity
17%
brain
17%
in vivo
17%
chains
16%
design
16%
liver
16%
molecules
16%
populations
16%
interactions
15%
heparin
15%
tissues
15%
toxicity
14%
kinases
14%
lysosomes
14%
tumors
14%
enzymes
14%
applications
13%
testing
13%
range
13%
membranes
12%
lipids
12%
kidneys
12%
therapy
12%
injuries
12%
vaccines
11%
polymers
11%
detection
11%
distribution
11%
monitoring
11%
tools
11%
messenger-rna
11%
nanoparticles
11%
indoles
11%
coronaviruses
11%
blood
10%
administration
10%
surfaces
10%
production
10%
spectra
10%
thrombosis
10%
screening
10%
epidermis
10%
regulations
10%
information
9%
oxidation
9%
biological markers
9%
losses
9%
aggregation
9%
investigations
9%
apoptosis
9%
women
9%
symptoms
9%
stability
9%
density
9%
motors
9%
mitochondria
9%
learning
9%
reagents
8%
interventions
8%
muscles
8%
mutations
8%
injection
8%
skin
8%
validation
8%
substrates
8%
lungs
8%
valence
8%